Article Sidebar

PDF (Tiếng Việt)
Published: 2021-10-30
Abstract Views: 402
Views PDF (Tiếng Việt): 435
DOI: https://doi.org/10.52852/tcncyh.v145i9.390
Issue
Vol. 145 No. 9 (2021)
Section
Các bài báo
How to Cite
Huy, V. X., Bùi, V. Q., Nghĩa , N. V., Lâm, P. S., Cương, Đỗ T., Hoàng, N. C., & Dương, P. T. (2021). Results of the volumetric modulated arc therapy (vmat) in the treatment of prostate cancer at National K hospital. Journal of Medical Research, 145(9), 212-220. https://doi.org/10.52852/tcncyh.v145i9.390

Results of the volumetric modulated arc therapy (vmat) in the treatment of prostate cancer at National K hospital

Vũ Xuân Huy, Vinh Quang Bùi, Nguyễn Viết Nghĩa, Phạm Sơn Lâm, Đỗ Tất Cương, Nguyễn Công Hoàng, Phan Thanh Dương

Main Article Content

Abstract

This study was performed to assess the effectiveness of VMAT (Volumetric modulated Arc Therapy) for prostate cancer treatment at the Vietnam National Oncology Hospital. A retrospective analysis of VMAT plans was performed for 30 prostate cancer patients treated during the period of September 2017 to June 2021 at Vietnam National Oncology Hospital. Results showed that the average age of diagnosis is 69 years old. The percentages of patient diagnosed at stages I – IV were 3.3%, 33.3%, 36.7% and 26.7% respectively. 100% of patients treated have PSA level < 4ng/ml. Acute grade 1 genitourinary (GU) toxicity was found in 73.7% of patients and G1 gastrointestinal (GI) toxicity in 26.7% of patients. G1 late genitourinary toxicity accounted for 30%, patients with G1 were 20%. There was no patient with late toxicity G3 and G4 symptoms, no patient with skeletal complications. Thus, this study showed that patients treated with VMAT had less adverse affects in comparison with those who were treated with 3D-CRT, shorter treatment duration than those receiving IMRT treatment and disease progression free survival time prolonged.

Article Details

Keywords

VMAT, IMRT, Ung thư tuyến tiền liệt

References

1. Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci. 2006 May 1;11:1388 - 413. doi: 10,2741/1891. PMID: 16368524.
2. Boyle P, Severi G, Giles GG. The epidemiology of prostate cancer. Urol Clin North Am. 2003 May;30(2):209 - 17. doi: 10,1016/s0094 - 0143(02)00181 - 7. PMID: 12735498.
3. Bộ Y tế (2020), Hướng dẫn chẩn đoán và điều trị một số bệnh ung bướu,
4. Abu - Hijlih R. Volumetric - modulated arc therapy versus intensity - modulated radiotherapy for localized prostate cancer: a dosimetric comparative analysis of moderate hypofractionated radiation. Oncology and Radiotherapy 2020 Oct, Vol. 14.
5. Keung EZ, Gershenwald JE. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther. 2018 Aug;18(8):775 - 784. doi: 10,1080/14737140,2018.1489246. PMID: 29923435; PMCID: PMC7652033.
6. Nguyễn Tiến Đệ (2015). Đánh giá kết quả sớm của phẫu thuật nội soi ngoài phúc mạc cắt tuyến tiền liệt tận gốc, Luận án tiến sĩ y học, Trường đại học Y dược thành phố Hồ Chí Minh.
7. Cakir, A., Akgun, Z., Fayda, M., & Agaoglu, F. (2015). Comparison of Three Dimensional Conformal Radiation Therapy, Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Low Radiation Exposure of Normal Tissue in Patients with Prostate Cancer. Asian Pacific Journal of Cancer Prevention, 16(8), 3365–3370, https://doi.org/10,7314/apjcp.2015.16.8.3365
8. Huang SY, Wu CT, Liu DW, Wang TH, Liao YH, Chen YW, Hsu WL. Dose escalation (81 Gy) with image - guided radiation therapy and volumetric - modulated arc therapy for localized prostate cancer: A retrospective preliminary result. Ci Ji Yi Xue Za Zhi. 2019 Jun 24;32(1):75 - 81. doi: 10,4103/tcmj.tcmj_2_19. PMID: 32110525; PMCID: PMC7015011.
9. Doležel M, Odrážka K, Vaňásek J, Štuk J, Hlávka A, Vítková M, Ulrych V, Kohlová T, Vlachová Z, Hafuda A, Hartmann I. Long - Term Clinical Results of IGRT in Prostate Cancer Treatment. Klin Onkol. 2020 Winter;33(1):49 - 54. English. doi: 10,14735/amko202049. PMID: 32075389.
10, Shiraishi K, Futaguchi M, Haga A, Sakumi A, Sasaki K, Yamamoto K, Igaki H, Ohtomo K, Yoda K, Nakagawa K. Validation of planning target volume margins by analyzing intrafractional localization errors for 14 prostate cancer patients based on three - dimensional cross - correlation between the prostate images of planning CT and intrafraction cone - beam CT during volumetric modulated arc therapy. Biomed Res Int. 2014;2014:960928. doi: 10,1155/2014/960928. Epub 2014 May 22. PMID: 24977167; PMCID: PMC4055024.
11. Hostova B, Matula P, Dubinsky P. Prediction of toxicities of prostate cancer radiotherapy. Neoplasma. 2016;63(1):163 - 168. doi:10,4149/neo_2016_020
12. Arcangeli G, Fowler J, Gomellini S, Arcangeli S, Saracino B, Petrongari MG, Benassi M, Strigari L. Acute and late toxicity in a randomized trial of conventional versus hypofractionated three - dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1013 - 21. doi: 10,1016/j.ijrobp.2009.12.045. Epub 2010 May 5. PMID: 20447774.
13. Marzi S, Arcangeli G, Saracino B, Petrongari MG, Bruzzaniti V, Iaccarino G, Landoni V, Soriani A, Benassi M. Relationships between rectal wall dose - volume constraints and radiobiologic indices of toxicity for patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):41 - 9. doi: 10,1016/j.ijrobp.2006.12.003. Epub 2007 Feb 2. PMID: 17276615.